BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

Free Newsletters
My Subscriptions

News by Subject
News by Disease
News by Date
Search News
Post Your News

Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Pharm Country
  Bio NC
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™


Company Profiles

Research Store

Research Events
Post an Event
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile


PerkinElmer, Inc. 

940 Winter Street

Waltham  Massachusetts  02451  U.S.A.
Phone: 781-663-6900 Fax:


PerkinElmer, Inc. is a global technology leader providing scientific instruments, consumables and services to the pharmaceutical, biomedical, environmental testing and general industrial markets that require innovation, precision and reliability. We design, manufacture, market and service products and systems within three business units: Life and Analytical Sciences, Optoelectronics and Fluid Sciences.

Facts about PerkinElmer

  • 2003 Revenue $1.535 Billion
  • Operating in 125 countries
  • 10,000 employees
  • Member S&P 500 Index

    PerkinElmer Life and Analytical Sciences

    549 Albany Street
    Boston, MA 02118, USA
    Telephone General Information 617-482-9595 or Customer Care 800-762-4000 (USA only)

    A $1 billion market leader, PerkinElmer LAS serves a number of growing industries and markets including the academic research, biotechnology, clinical screening, pharmaceutical, environmental, forensic, petrochemical and semiconductor segments. Our instruments, reagents, consumables and service offerings help our customers solve complex analytical problems encountered in drug discovery and genetic screening laboratories. Our instruments and related software applications measure a range of substances from biomolecular matter to organic and inorganic materials. Our total application-driven laboratory solutions help our customers speed drug discovery, enhance research productivity, meet strict regulatory requirements, improve time-to-market, and increase manufacturing efficiencies.

    Last Updated: 12-14-04

     Key Statistics

    Ownership: Public

    Web Site: PerkinElmer, Inc.
    Symbol: PKI

  • Industry

     Company News
    PerkinElmer, Inc. (PKI) Announces First Commercial Availability Of Newborn Screening Test For Severe Combined Immunodeficiency (SCID) In U.S. and Canada 12/18/2014 11:59:58 AM
    PerkinElmer, Inc. (PKI) Completes Acquisition Of Perten Instruments 12/16/2014 11:03:28 AM
    OncoSec Medical Inc. Collaborates With PerkinElmer, Inc. (PKI) And University of California, Los Angeles (UCLA) To Evaluate Patient-Selection Biomarker In Immunotherapy 12/2/2014 11:52:57 AM
    PerkinElmer, Inc. (PKI) Enters Into Definitive Agreement To Acquire Perten Instruments 11/24/2014 8:48:51 AM
    PerkinElmer, Inc. (PKI) To Present At Piper Jaffray Healthcare Conference 11/20/2014 1:44:39 PM
    PerkinElmer, Inc. (PKI) To Present At Jefferies and Co. 2014 Global Healthcare Conference 11/11/2014 9:13:29 AM
    PerkinElmer, Inc. (PKI) Announces Financial Results For The Third Quarter Of 2014 10/31/2014 9:09:30 AM
    PerkinElmer, Inc. (PKI) Acquires Ceiba Solutions, Inc. 10/30/2014 10:40:37 AM
    PerkinElmer, Inc. (PKI) Board Declares Quarterly Dividend 10/24/2014 9:31:33 AM
    PerkinElmer, Inc. (PKI) Launches Mantra™ Quantitative Pathology Imaging System For Cancer Immunology Research 10/23/2014 11:14:37 AM